TherapeuticsMD Inc - Asset Resilience Ratio
TherapeuticsMD Inc (TXMD) has an Asset Resilience Ratio of 0.13% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does TherapeuticsMD Inc carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2017)
This chart shows how TherapeuticsMD Inc's Asset Resilience Ratio has changed over time. See TXMD net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down TherapeuticsMD Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see TherapeuticsMD Inc (TXMD) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $68.41K | 0.13% |
| Total Liquid Assets | $68.41K | 0.13% |
Asset Resilience Insights
- Limited Liquidity: TherapeuticsMD Inc maintains only 0.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
TherapeuticsMD Inc Industry Peers by Asset Resilience Ratio
Compare TherapeuticsMD Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 9.09% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.02% |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
Annual Asset Resilience Ratio for TherapeuticsMD Inc (2011–2017)
The table below shows the annual Asset Resilience Ratio data for TherapeuticsMD Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 0.00% | $0.00 | $143.23 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $142.47 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $73.73 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $59.08 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $62.02 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $5.82 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $1.44 Million | -- |
About TherapeuticsMD Inc
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors an… Read more